How does a microwave hyperthermia system work for cancer treatment and what frequencies are used?
Microwave Hyperthermia Systems for Oncology
Microwave hyperthermia is used as an adjunct therapy (combined with radiation or chemotherapy) for various cancers including breast, cervical, head and neck, bladder, and melanoma. Clinical trials have shown 20-30% improvement in tumor control rates when hyperthermia is added to radiation therapy.
- Performance verification: confirm specifications against the application requirements before finalizing the design
- Environmental factors: temperature range, humidity, and vibration affect long-term reliability and parameter drift
- Cost vs. performance: evaluate whether the application demands premium components or standard commercial grades
- Interface compatibility: verify impedance, connector type, and mechanical form factor match the system architecture
- Margin allocation: include sufficient design margin to account for manufacturing tolerances and aging effects
Frequently Asked Questions
How does hyperthermia kill cancer cells?
Hyperthermia at 40-45 degrees C damages cancer cells through several mechanisms: protein denaturation (disrupting cellular enzymes and structural proteins), increased membrane permeability (causing ion imbalance), impaired DNA repair (preventing cells from fixing radiation damage), and enhanced blood flow (improving drug delivery and oxygenation). Cancer cells are more susceptible to heat damage than normal cells because tumors have poor blood supply (disorganized vasculature), limiting their ability to dissipate heat and maintain homeostasis.
Is hyperthermia the same as thermal ablation?
No. Hyperthermia heats tissue to 40-45 degrees C (sub-lethal), weakening the cancer cells and making them more susceptible to radiation or chemotherapy. The cells die from the combined treatment. Thermal ablation heats tissue to 60-100 degrees C (lethal), directly killing all cells in the heated volume through coagulative necrosis. Ablation is a standalone treatment; hyperthermia is always used in combination with other therapies.
What are the main engineering challenges?
Precise focusing (steering the SAR focus to the tumor while minimizing heating of surrounding normal tissue), patient-specific treatment planning (each patient's anatomy is different, requiring individualized phase/amplitude optimization), temperature monitoring (knowing the actual 3D temperature distribution during treatment is critical for safety and efficacy), and deep heating (for tumors deeper than 5 cm, the electromagnetic field attenuates significantly, making adequate heating challenging with external applicators at available frequencies).